Optimization · Research guide

Creatine for dogs: a credible muscle idea with an unfinished clinical story

Dogs can absorb supplemental creatine. Whether it reliably improves strength, muscle or healthy ageing is a different question.

The takeaway

Nara’s take.

Creatine is worth understanding, not dismissing. Its energy-buffering role is real and canine exposure studies exist. What is missing is convincing dog-specific evidence that supplementation produces the muscle or functional benefits owners are hoping for.

How it may work

What creatine does inside a muscle cell

The creatine–phosphocreatine system helps regenerate ATP, the immediately usable energy currency of cells. In muscle, that makes it particularly relevant to repeated demands for rapid energy rather than simply adding dietary calories.

Human resistance-training research gives the canine question a sensible starting point. It does not establish how much headroom dogs have, whether their usual diets alter their response, or what training stimulus would be needed to produce a useful effect.

Sources: [1], [2], [3]

What the research shows

There is dog research—but it answers a narrower question

A 1998 study examined plasma and muscle creatine responses to dietary supplementation. A 2022 crossover feeding study in eight adult Beagles tested a combination of creatine, carnitine and choline and measured post-meal blood changes.

The later study found increases in circulating creatine and creatinine. That demonstrates exposure under the tested conditions; it did not measure stronger dogs, better mobility or longer life. The combination formulation also limits what can be attributed to creatine alone. Short feeding periods cannot establish the safety of years of use.

Sources: [1], [2]

Nara's interpretation

Why the creatinine detail matters

Creatine and creatinine are related but are not the same thing. Because creatinine is also used in kidney assessment, supplementation can add context to a laboratory result. A rise should not automatically be called kidney damage—or automatically dismissed as harmless.

Nara would keep the product and timing visible to the clinician interpreting the results. The clinical picture, trend and other tests still matter. This is a reason for better records, not a way to explain away an abnormal result at home.

Evidence informing this guidance: [2], [4]

Nara's practical guidance

What this means for your dog

The foundation of a muscle plan remains adequate food, suitable loading and attention to pain or disease. Creatine's human reputation cannot supply an established canine loading protocol, an ideal dose or proof that an inactive dog will gain useful muscle.

Nara treats it as a research-led discussion rather than a routine prescription, particularly when kidney disease or unexplained laboratory changes are present. The powder itself may be inexpensive, but uncertain benefit and monitoring still carry a burden. A controlled canine trial measuring strength, mobility and lean tissue together would meaningfully change this conversation.

Evidence informing this guidance: [2], [3], [5]

Follow the evidence

Sources and review notes.

Primary studies, clinical guidance and explicitly labelled sponsor disclosures. A mechanism, an observational association and a treatment result are different kinds of evidence.

Editorial research update: 2026-09-24. These guides build on Nara’s existing source records and a fresh check of accessible primary abstracts, full texts and official pages. This is not an exhaustive systematic review or a new independent clinical review. The evidence assessment retains its own date and status. Practical examples are Nara’s interpretation, not validated treatment protocols.

[1] 1998 · dog · dietary pharmacology and biomarker study
Changes in Plasma and Muscle Creatine Concentration after Increases in Supplementary Dietary Creatine in Dogs
Lowe JA, Murphy M, Nash V. Journal of Nutrition.
10.1093/jn/128.12.2691S
Establishes oral creatine bioavailability and tissue/plasma response, not clinical efficacy.
[2] 2022 · dog · small crossover feeding pharmacokinetic/biomarker study
Addition of a combination of creatine, carnitine, and choline to a commercial diet increases postprandial plasma creatine and creatinine concentrations in adult dogs
Banton S, Braun U, Squires EJ, Shoveller AK. Frontiers in Veterinary Science.
10.3389/fvets.2022.1063169
Shows circulating creatine and creatinine effects; does not establish canine functional efficacy.
[3] 2015 · human · randomized resistance-training intervention
Strategic creatine supplementation and resistance training in healthy older adults
Candow DG, Forbes SC, Little JP, Cornish SM, Pinkoski C, Chilibeck PD. Applied Physiology, Nutrition, and Metabolism.
10.1139/apnm-2014-0498
Human aging/sports translational evidence; explicitly not canine efficacy evidence.
[4] 2021 · dog · longitudinal biochemical-variation study
Variation in biochemistry test results between annual wellness visits in apparently healthy Golden Retrievers
Jeffery U et al.. Journal of Veterinary Internal Medicine.
10.1111/jvim.16021
Supports within-dog longitudinal interpretation and reference-change concepts.
[5] 2023 · Dog and cat; this guide uses the dog-specific guidance · Veterinary clinical guideline, not an intervention trial
2023 AAHA Senior Care Guidelines for Dogs and Cats: Nutrition
American Animal Hospital Association. AAHA.
Official guideline, nutrition section
Nutritional assessment, muscle loss, appropriate energy and protein in older dogs.

Keep reading

Connected questions.

Muscle preservation

Defending lean mass through mid and late life, rather than reacting to visible loss.

Protein adequacy

Whether an ageing dog is getting enough high-quality protein to defend lean mass.

Exercise

Volume, intensity, and variety of loading across a dog's week.

Open Nara’s evidence assessment

The guide above explains the topic. This separate record preserves the accepted claim, confidence, limitations and safety context. Publishing an article does not upgrade the science or turn an experimental intervention into a recommendation.

Nara’s evidence view

Research watchlist

PreliminaryCanine biomarkersLow confidence

The claim we’re evaluating

Routine creatine supplementation in generally healthy dogs improves muscle performance, body composition, cognition, recovery, or healthy-aging outcomes beyond a nutritionally adequate diet.

Nara’s interpretation

Canine creatine research establishes oral bioavailability and measurable changes in circulating or tissue creatine, but it does not establish routine performance, body-composition, cognitive, recovery, or healthy-aging benefit in dogs. Human resistance-training research makes those uses biologically plausible but is not canine efficacy evidence and has itself produced heterogeneous results. Creatine-containing supplementation can also transiently alter measured creatinine in dogs, which matters for laboratory interpretation but is neither proof of kidney injury nor proof of individual renal safety.

How we reached this view

What the evidence shows

A 1998 canine study showed that increasing dietary creatine changed plasma and muscle creatine concentrations, establishing biological availability rather than a clinically meaningful outcome. A 2022 study in eight healthy adult Beagles found that a top-dressed combination containing creatine, carnitine, and choline increased postprandial plasma creatine and creatinine; its short duration, small sample, combination formulation, and biomarker focus prevent efficacy conclusions. Human trials in older adults provide direct human evidence that creatine combined with resistance training can improve some strength or lean-mass outcomes, while other trials report little or no additional benefit. The phosphocreatine energy-buffering mechanism is biologically relevant but does not demonstrate a canine outcome.

Important limitations

Peer-reviewed canine efficacy evidence for meaningful performance, body-composition, cognitive, recovery, or aging outcomes is extremely sparse.
The 1998 dog study primarily addressed creatine concentrations rather than clinical or functional outcomes.
The 2022 dog study used only eight Beagles, short feeding periods, and a creatine-carnitine-choline combination, so effects cannot be attributed solely to creatine beyond its measured concentration changes.
Available canine studies do not establish long-term safety across kidney disease, medication exposure, aging, or other clinical contexts.

What would change Nara’s view

What would strengthen our view

Independent randomized canine trials demonstrating reproducible improvement in objective strength, performance, lean mass, physical function, cognition, or recovery.
Long-duration canine safety studies incorporating renal function assessment that is not dependent solely on serum creatinine.

What could weaken our view

Adequately powered canine efficacy trials showing no meaningful functional benefit despite confirmed creatine exposure.
Reproducible long-term canine adverse outcomes attributable to creatine rather than laboratory-marker interference.

What could change our position

Replicated, clinically meaningful canine efficacy with an acceptable safety profile could move creatine from research_watchlist to reasonable_to_consider.
A reproducible clinically important canine harm signal could move the relevant use toward potential_concern.

Safety and clinical context

Creatine-containing supplementation can increase measured creatinine, so a creatinine change after exposure must not automatically be interpreted as either kidney damage or benignity.
Existing canine research does not establish medical eligibility for a dog with abnormal renal markers, kidney disease, medication exposure, dehydration, or another clinical issue.
Human safety experience must not be substituted for dog-specific clinical clearance.

Evidence record

Nara position: Research watchlist
Evidence maturity: Preliminary
Most direct relevant evidence: Canine biomarkers
Overall confidence: Low confidence
Evidence reviewed through: 2026-08-12
Assessment date: 2026-08-12
Review status: Initial Nara internal evidence assessment
Framework: Nara Evidence Framework v1.0

How Nara evaluates science

Anchor sources

Changes in Plasma and Muscle Creatine Concentration after Increases in Supplementary Dietary Creatine in Dogs

Journal of Nutrition · 1998 · dog

dietary pharmacology and biomarker study

Establishes oral creatine bioavailability and tissue/plasma response, not clinical efficacy.

10.1093/jn/128.12.2691S

Addition of a combination of creatine, carnitine, and choline to a commercial diet increases postprandial plasma creatine and creatinine concentrations in adult dogs

Frontiers in Veterinary Science · 2022 · dog

small crossover feeding pharmacokinetic/biomarker study

Shows circulating creatine and creatinine effects; does not establish canine functional efficacy.

10.3389/fvets.2022.1063169

Strategic creatine supplementation and resistance training in healthy older adults

Applied Physiology, Nutrition, and Metabolism · 2015 · human

randomized resistance-training intervention

Human aging/sports translational evidence; explicitly not canine efficacy evidence.

10.1139/apnm-2014-0498

The effects of supplementation with creatine and protein on muscle strength following a traditional resistance training program in middle-aged and older men

Journal of Nutrition, Health and Aging · 2010 · human

resistance-training supplementation trial

Useful contradictory or less-supportive human evidence against assuming a universal creatine effect.

PMID 20126965

Your dog’s context

Bring this back to your dog.

Loading your dog’s context…